Markets

Medical Devices ETF (IHI) Hits New 52-Week High

Investors seeking momentum may have iShares U.S. Medical Devices ETF (IHI) on radar now. The fund recently hit a new 52-week high. Shares of IHI are up approximately 72.6% from their 52-week low of $183.25/share.

But could there be more gains ahead for this ETF? Let’s take a look at the fund and the near-term outlook to get a better idea of where it might be headed.

IHI in Focus

The underlying Dow Jones U.S. Select Medical Equipment Index measures the performance of the medical equipment sector of the U.S. equity market. The fund charges investors 42 basis points in fee per year (see all Healthcare ETFs here).

Why the move?

The fund is probably an election beneficiary. Democratic nominee Joe Biden intends to expand Medicaid and Medicare while protecting the ACA.Per Chantico Global CEO Gina Sanchez, Biden wants to increase equipment manufacturing, to increase testing and tracing, and all the procedures that are tied with Covid. Since Biden has considerable chances of winning, this medical devices ETF hit a 52-week high.

More Gains Ahead?

The fund has a positive weighted alpha of 32.60. So, there is a decent outlook ahead for those who want to ride this surging ETF a shade further.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
iShares U.S. Medical Devices ETF (IHI): ETF Research Reports
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
 
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

ETFs

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More